MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications ...
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral ...
MAIA Biotechnology's shares rose 19% to $2.46 after the company said it entered into a clinical supply agreement with BeiGene to evaluate THIO, MAIA's telomere-targeting anticancer agent.
MAIA Biotechnology (MAIA) announced that it has entered into a clinical supply agreement with BeiGene (BGNE) to assess the efficacy of THIO, ...
Health-care companies rose as a reported U.S. death from bird flu stoked fears of a new pandemic, boosting shares of vaccine makers.
My 2024 picks outperformed the S&P 500, mainly due to Tesla, but small biotech firms lagged significantly. Learn more about ...
A New York appellate court on Tuesday denied President-elect Donald Trump's bid to halt sentencing set for Friday for his conviction on criminal charges stemming from hush money paid to a porn ...
Ukraine's air force says one of its F-16 fighter jet pilots shot down six missiles during a Russian aerial attack last month. Meanwhile, Moscow says its troops have inflicted a series of defeats ...
Tens of Thousands Ordered to Flee From L.A. Fire Pacific Palisades, Calif. LIVE Homes Destroyed as Officials Warn Worst Is Yet to Come Rapidly moving flames fanned by strong Santa Ana winds ...
A force fighting Sudan’s army in a brutal civil war committed massacres and rape that amount to genocide, the Secretary of State said, two decades after a finding of genocide in the same region ...
Gastric cancer, commonly known as stomach cancer, is the fifth most common cancer globally and the fifth leading cause of ...
F5, Inc. announced it will report its first quarter fiscal year 2025 financial results on Tuesday, January 28, 2025 following the market close. F5 also will host a live webcast to discuss its results ...